{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:01:45Z","timestamp":1792173705368,"version":"4.4.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jpsychires.2021.11.025","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T21:10:54Z","timestamp":1637097054000},"page":"367-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Modulating neuroinflammation in COVID-19 patients with obsessive-compulsive disorder"],"prefix":"10.1016","volume":"149","author":[{"given":"Vera","family":"Nezgovorova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casara Jean","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Pallanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4196-0596","authenticated-orcid":false,"given":"Eric","family":"Hollander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.jpsychires.2021.11.025_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17196986","article-title":"COVID-19 pandemic and mental health: prevalence and correlates of new-onset obsessive-compulsive symptoms in a Canadian province","volume":"17","author":"Abba-Aji","year":"2020","journal-title":"Int. J. Environ. Res. Publ. Health"},{"issue":"7862","key":"10.1016\/j.jpsychires.2021.11.025_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-021-03553-9","article-title":"High-dimensional characterization of post-acute sequelae of COVID-19","volume":"594","author":"Al-Aly","year":"2021","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jpsychires.2021.11.025_bib3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00213-020-05753-z","article-title":"Fluvoxamine, melatonin and COVID-19","volume":"238","author":"Anderson","year":"2021","journal-title":"Psychopharmacology (Berlin)"},{"issue":"1","key":"10.1016\/j.jpsychires.2021.11.025_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbi.2010.08.003","article-title":"Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome","volume":"25","author":"Ashwood","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jpsychires.2021.11.025_bib5","doi-asserted-by":"crossref","first-page":"112966","DOI":"10.1016\/j.psychres.2020.112966","article-title":"The other side of COVID-19: impact on obsessive-compulsive disorder (OCD) and hoarding","volume":"288","author":"Banerjee","year":"2020","journal-title":"Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.jpsychires.2021.11.025_bib6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.biopsych.2013.09.023","article-title":"The epidemiologic evidence linking autoimmune diseases and psychosis","volume":"75","author":"Benros","year":"2014","journal-title":"Biol. Psychiatr."},{"issue":"8","key":"10.1016\/j.jpsychires.2021.11.025_bib7","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/mp.2009.50","article-title":"Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder","volume":"15","author":"Bloch","year":"2010","journal-title":"Mol. Psychiatr."},{"issue":"6","key":"10.1016\/j.jpsychires.2021.11.025_bib8","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jamapsychiatry.2021.0500","article-title":"How COVID-19 affects the brain","volume":"78","author":"Boldrini","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.jpsychires.2021.11.025_bib9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-019-02009-9","article-title":"Neuroinflammation, the thread connecting neurological disease : cluster: \u201cNeuroinflammatory mechanisms in neurodegenerative disorders\u201d","volume":"137","author":"Brambilla","year":"2019","journal-title":"Acta Neuropathol."},{"issue":"7","key":"10.1016\/j.jpsychires.2021.11.025_bib10","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1158\/1055-9965.EPI-20-0606","article-title":"The COronavirus pandemic epidemiology (cope) consortium: a call to action","volume":"29","author":"Chan","year":"2020","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"3","key":"10.1016\/j.jpsychires.2021.11.025_bib11","doi-asserted-by":"crossref","first-page":"E313","DOI":"10.1148\/radiol.2020202422","article-title":"Retrospective observational study of brain MRI findings in patients with acute SARS-CoV-2 infection and neurologic manifestations","volume":"297","author":"Chougar","year":"2020","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.jpsychires.2021.11.025_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2141","article-title":"Interleukin-6 in Covid-19: a systematic review and meta-analysis","volume":"30","author":"Coomes","year":"2020","journal-title":"Rev. Med. Virol."},{"issue":"10","key":"10.1016\/j.jpsychires.2021.11.025_bib13","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.3174\/ajnr.A6712","article-title":"Bilateral basal ganglia hemorrhage in a patient with confirmed COVID-19","volume":"41","author":"Daci","year":"2020","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.jpsychires.2021.11.025_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bbr.2016.08.005","article-title":"Fluvoxamine maleate normalizes striatal neuronal inflammatory cytokine activity in a Parkinsonian rat model associated with depression","volume":"316","author":"Dalle","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.jpsychires.2021.11.025_bib15","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.7861\/clinmed.2020-0896","article-title":"Autonomic dysfunction in \u2019long COVID\u2019: rationale, physiology and management strategies","volume":"21","author":"Dani","year":"2021","journal-title":"Clin. Med."},{"key":"10.1016\/j.jpsychires.2021.11.025_bib16","doi-asserted-by":"crossref","first-page":"113213","DOI":"10.1016\/j.psychres.2020.113213","article-title":"The impact of the COVID-19 pandemic on patients with OCD: effects of contamination symptoms and remission state before the quarantine in a preliminary naturalistic study","volume":"291","author":"Davide","year":"2020","journal-title":"Psychiatr. Res."},{"issue":"15","key":"10.1016\/j.jpsychires.2021.11.025_bib17","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1517\/14656566.6.15.2727","article-title":"Fluvoxamine: a selective serotonin reuptake inhibitor for the treatment of obsessive-compulsive disorder","volume":"6","author":"Dell'Osso","year":"2005","journal-title":"Expet Opin. Pharmacother."},{"issue":"10","key":"10.1016\/j.jpsychires.2021.11.025_bib18","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/archneur.58.10.1696","article-title":"von Economo encephalitis","volume":"58","author":"Dickman","year":"2001","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.jpsychires.2021.11.025_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/wps.20724","article-title":"Inflammation affects social experience: implications for mental health","volume":"19","author":"Eisenberger","year":"2020","journal-title":"World Psychiatr."},{"key":"10.1016\/j.jpsychires.2021.11.025_bib20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cytogfr.2020.06.009","article-title":"COVID-19 infection may increase the risk of parkinsonism - remember the Spanish flu?","volume":"54","author":"Eldeeb","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"9","key":"10.1016\/j.jpsychires.2021.11.025_bib21","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","article-title":"Neurological associations of COVID-19","volume":"19","author":"Ellul","year":"2020","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.jpsychires.2021.11.025_bib22","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000490002","article-title":"Inflammation: a contributor to depressive comorbidity in inflammatory skin disease","volume":"31","author":"Farzanfar","year":"2018","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.jpsychires.2021.11.025_bib23","doi-asserted-by":"crossref","first-page":"5954897","DOI":"10.1155\/2018\/5954897","article-title":"Influence of biological therapeutics, cytokines, and disease activity on depression in rheumatoid arthritis","volume":"2018","author":"Figueiredo-Braga","year":"2018","journal-title":"J. Immunol. Res."},{"issue":"6","key":"10.1016\/j.jpsychires.2021.11.025_bib24","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/YIC.0000000000000237","volume":"33","author":"Fineberg","year":"2018","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2021.11.025_bib25","doi-asserted-by":"crossref","first-page":"152174","DOI":"10.1016\/j.comppsych.2020.152174","volume":"100","author":"Fineberg","year":"2020","journal-title":"Compr. Psychiatr."},{"issue":"6","key":"10.1016\/j.jpsychires.2021.11.025_bib26","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/da.23037","article-title":"The impact of coronavirus (COVID-19) in the diagnosis and treatment of obsessive-compulsive disorder","volume":"37","author":"Fontenelle","year":"2020","journal-title":"Depress. Anxiety"},{"issue":"6","key":"10.1016\/j.jpsychires.2021.11.025_bib27","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.comppsych.2011.12.007","article-title":"A cytokine study of adult patients with obsessive-compulsive disorder","volume":"53","author":"Fontenelle","year":"2012","journal-title":"Compr. Psychiatr."},{"issue":"7","key":"10.1016\/j.jpsychires.2021.11.025_bib28","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3174\/ajnr.A6595","article-title":"Hemorrhagic posterior reversible encephalopathy syndrome as a manifestation of COVID-19 infection","volume":"41","author":"Franceschi","year":"2020","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.jpsychires.2021.11.025_bib29","doi-asserted-by":"crossref","first-page":"100053","DOI":"10.1016\/j.clinpr.2020.100053","article-title":"COVID-19-associated encephalitis successfully treated with combination therapy","volume":"7","author":"Freire-Alvarez","year":"2020","journal-title":"Clin. Infect Pract."},{"issue":"4","key":"10.1016\/j.jpsychires.2021.11.025_bib30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1017\/ipm.2020.61","article-title":"Acute exacerbation of OCD symptoms precipitated by media reports of COVID-19","volume":"37","author":"French","year":"2020","journal-title":"Ir. J. Psychol. Med."},{"issue":"2","key":"10.1016\/j.jpsychires.2021.11.025_bib31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1176\/appi.ajp.157.2.281","article-title":"MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection","volume":"157","author":"Giedd","year":"2000","journal-title":"Am. J. Psychiatr."},{"issue":"6","key":"10.1016\/j.jpsychires.2021.11.025_bib32","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/npp.2017.258","article-title":"A randomized, double-blind, placebo-controlled clinical trial of tocilizumab, an interleukin-6 receptor antibody, for residual symptoms in schizophrenia","volume":"43","author":"Girgis","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.jpsychires.2021.11.025_bib33","first-page":"257","article-title":"Obsessive-compulsive disorder","volume":"37","author":"Goodman","year":"2014","journal-title":"Psychiatr. Clin."},{"key":"10.1016\/j.jpsychires.2021.11.025_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cytogfr.2020.05.009","article-title":"IL-6: Relevance for immunopathology of SARS-CoV-2","volume":"53","author":"Gubernatorova","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"10","key":"10.1016\/j.jpsychires.2021.11.025_bib35","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1517\/17425255.4.10.1265","article-title":"Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment","volume":"4","author":"Harry","year":"2008","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"1","key":"10.1016\/j.jpsychires.2021.11.025_bib36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2020.05.008","article-title":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19","volume":"146","author":"Herold","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"9","key":"10.1016\/j.jpsychires.2021.11.025_bib37","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1038\/s41380-021-01021-4","article-title":"Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study","volume":"26","author":"Hoertel","year":"2021","journal-title":"Mol. Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2021.11.025_bib38","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/bph.13175","article-title":"Immunoinflammatory diseases of the central nervous system - the tale of two cytokines","volume":"173","author":"Hofer","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpsychires.2021.11.025_bib39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s41232-020-00146-3","article-title":"How COVID-19 induces cytokine storm with high mortality","volume":"40","author":"Hojyo","year":"2020","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.jpsychires.2021.11.025_bib41","series-title":"Classification of Diseases (ICD-10)","author":"International","year":"2010"},{"issue":"2","key":"10.1016\/j.jpsychires.2021.11.025_bib43","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/mp.2016.167","article-title":"Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions","volume":"23","author":"Kappelmann","year":"2018","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2021.11.025_bib44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.comppsych.2018.11.013","article-title":"Blood levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha and cognitive functions in patients with obsessive compulsive disorder","volume":"89","author":"Karaguzel","year":"2019","journal-title":"Compr. Psychiatr."},{"issue":"5","key":"10.1016\/j.jpsychires.2021.11.025_bib45","first-page":"4195","article-title":"Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis","volume":"55","author":"Kohler","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jpsychires.2021.11.025_bib46","first-page":"B326","article-title":"[Encephalitis lethargica in The Netherlands; renewed interest in a mysterious disease]","volume":"153","author":"Koning","year":"2009","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"10.1016\/j.jpsychires.2021.11.025_bib47","doi-asserted-by":"crossref","first-page":"65704","DOI":"10.1155\/2007\/65704","article-title":"Plasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorder","volume":"2007","author":"Konuk","year":"2007","journal-title":"Mediat. Inflamm."},{"issue":"13","key":"10.1016\/j.jpsychires.2021.11.025_bib48","doi-asserted-by":"crossref","first-page":"e1868","DOI":"10.1212\/WNL.0000000000010112","article-title":"Neurologic and neuroimaging findings in patients with COVID-19: a retrospective multicenter study","volume":"95","author":"Kremer","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jpsychires.2021.11.025_bib49","doi-asserted-by":"crossref","first-page":"102053","DOI":"10.1016\/j.ajp.2020.102053","article-title":"Dealing with Corona virus anxiety and OCD","volume":"51","author":"Kumar","year":"2020","journal-title":"Asian J Psychiatr"},{"issue":"3","key":"10.1016\/j.jpsychires.2021.11.025_bib50","doi-asserted-by":"crossref","first-page":"151913","DOI":"10.1016\/j.imbio.2020.151913","article-title":"Novel inflammatory targets for immunotherapies in pediatric patients with trichotillomania","volume":"225","author":"Kutuk","year":"2020","journal-title":"Immunobiology"},{"issue":"22","key":"10.1016\/j.jpsychires.2021.11.025_bib51","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.2020.22760","article-title":"Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial","volume":"324","author":"Lenze","year":"2020","journal-title":"J. Am. Med. Assoc."},{"issue":"12","key":"10.1016\/j.jpsychires.2021.11.025_bib52","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1212\/WNL.0000000000005176","article-title":"The centennial lesson of encephalitis lethargica","volume":"90","author":"Lutters","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jpsychires.2021.11.025_bib53","series-title":"\u2018Long-COVID\u2019: a Cross-Sectional Study of Persisting Symptoms, Biomarker and Imaging Abnormalities Following Hospitalisation for COVID-19","author":"Mandal","year":"2020"},{"key":"10.1016\/j.jpsychires.2021.11.025_bib54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.psyneuen.2018.04.013","article-title":"Immune system and obsessive-compulsive disorder","volume":"93","author":"Marazziti","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpsychires.2021.11.025_bib55","doi-asserted-by":"crossref","first-page":"567407","DOI":"10.3389\/fneur.2020.567407","article-title":"What does immunology have to do with normal brain development and the pathophysiology underlying tourette syndrome and related neuropsychiatric disorders?","volume":"11","author":"Martino","year":"2020","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.jpsychires.2021.11.025_bib56","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12264-017-0103-8","article-title":"The immune system, cytokines, and biomarkers in autism spectrum disorder","volume":"33","author":"Masi","year":"2017","journal-title":"Neurosci. Bull"},{"issue":"10229","key":"10.1016\/j.jpsychires.2021.11.025_bib57","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2021.11.025_bib58","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1016\/j.jpsychires.2021.11.025_bib59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1745-0179-4-13","article-title":"What every psychiatrist should know about PANDAS: a review","volume":"4","author":"Moretti","year":"2008","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"issue":"8","key":"10.1016\/j.jpsychires.2021.11.025_bib107","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1007\/s00415-020-10248-0","article-title":"Intravenous immunoglobulin therapy in COVID-19-related encephalopathy","volume":"268","author":"Muccioli","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.jpsychires.2021.11.025_bib61","doi-asserted-by":"crossref","first-page":"577400","DOI":"10.1016\/j.jneuroim.2020.577400","article-title":"COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment","volume":"349","author":"Muccioli","year":"2020","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.jpsychires.2021.11.025_bib62","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13304","article-title":"COVID-19 and Treg\/Th17 imbalance: potential relationship to pregnancy outcomes","volume":"84","author":"Muyayalo","year":"2020","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jpsychires.2021.11.025_bib63","doi-asserted-by":"crossref","first-page":"109783","DOI":"10.1016\/j.pnpbp.2019.109783","article-title":"Dysregulation in IL-6 receptors is associated with upregulated IL-17A related signaling in CD4+ T cells of children with autism","volume":"97","author":"Nadeem","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2021.11.025_bib64","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jpsychires.2021.11.025_bib65","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1186\/s12888-020-02905-5","article-title":"The immediate effect of COVID-19 pandemic on children and adolescents with obsessive compulsive disorder","volume":"20","author":"Nissen","year":"2020","journal-title":"BMC Psychiatr."},{"key":"10.1016\/j.jpsychires.2021.11.025_bib66","doi-asserted-by":"crossref","first-page":"615695","DOI":"10.3389\/fphar.2021.615695","article-title":"The anti-inflammatory effect of the tricyclic antidepressant clomipramine and its high penetration in the brain might Be useful to prevent the psychiatric consequences of SARS-CoV-2 infection","volume":"12","author":"Nobile","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2021.11.025_bib67","doi-asserted-by":"crossref","first-page":"379","DOI":"10.33549\/physiolres.934492","article-title":"COVID-19 and the immune system","volume":"69","author":"Paces","year":"2020","journal-title":"Physiol. Res."},{"issue":"2","key":"10.1016\/j.jpsychires.2021.11.025_bib68","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1176\/appi.ajp.2007.07111815","article-title":"Transcultural observations of obsessive-compulsive disorder","volume":"165","author":"Pallanti","year":"2008","journal-title":"Am. J. Psychiatr."},{"issue":"3","key":"10.1016\/j.jpsychires.2021.11.025_bib69","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/13651500701419685","article-title":"Treatment of depression with selective serotonin inhibitors: the role of fluvoxamine","volume":"11","author":"Pallanti","year":"2007","journal-title":"Int. J. Psychiatr. Clin. Pract."},{"key":"10.1016\/j.jpsychires.2021.11.025_bib70","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jpsychires.2020.08.008","article-title":"Neurocovid-19: a clinical neuroscience-based approach to reduce SARS-CoV-2 related mental health sequelae","volume":"130","author":"Pallanti","year":"2020","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.jpsychires.2021.11.025_bib71","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3345\/cep.2020.00493","article-title":"Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19)","volume":"63","author":"Park","year":"2020","journal-title":"Clin. Exp. Pediatr."},{"issue":"10","key":"10.1016\/j.jpsychires.2021.11.025_bib72","first-page":"713","article-title":"Socioeconomic status and survival in multiple myeloma","volume":"81","author":"Pasqualetti","year":"1990","journal-title":"Minerva Med."},{"issue":"7","key":"10.1016\/j.jpsychires.2021.11.025_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041623","article-title":"Soluble interleukin-6 receptor induces motor stereotypies and co-localizes with gp130 in regions linked to cortico-striato-thalamo-cortical circuits","volume":"7","author":"Patel","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jpsychires.2021.11.025_bib74","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1093\/brain\/awaa240","article-title":"The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings","volume":"143","author":"Paterson","year":"2020","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.jpsychires.2021.11.025_bib75","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/archpsyc.57.4.364","article-title":"Preliminary findings of antistreptococcal antibody titers and basal ganglia volumes in tic, obsessive-compulsive, and attention deficit\/hyperactivity disorders","volume":"57","author":"Peterson","year":"2000","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.jpsychires.2021.11.025_bib76","doi-asserted-by":"crossref","first-page":"595567","DOI":"10.3389\/fnhum.2020.595567","article-title":"Update on the use of transcranial electrical brain stimulation to manage acute and chronic COVID-19 symptoms","volume":"14","author":"Pilloni","year":"2020","journal-title":"Front. Hum. Neurosci."},{"issue":"5","key":"10.1016\/j.jpsychires.2021.11.025_bib77","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4088\/JCP.v67n0503","article-title":"The Brown Longitudinal Obsessive Compulsive Study: clinical features and symptoms of the sample at intake","volume":"67","author":"Pinto","year":"2006","journal-title":"J. Clin. Psychiatr."},{"issue":"12","key":"10.1016\/j.jpsychires.2021.11.025_bib78","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11920-017-0846-y","article-title":"Anxiety disorders and obsessive-compulsive disorder in individuals with autism spectrum disorder","volume":"19","author":"Postorino","year":"2017","journal-title":"Curr. Psychiatr. Rep."},{"issue":"3","key":"10.1016\/j.jpsychires.2021.11.025_bib79","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.psychres.2015.07.009","article-title":"Plasma cytokine abnormalities in drug-naive, comorbidity-free obsessive-compulsive disorder","volume":"229","author":"Rao","year":"2015","journal-title":"Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.jpsychires.2021.11.025_bib80","first-page":"R139","article-title":"The proinflammatory cytokine network: interactions in the CNS and blood of rhesus monkeys","volume":"274","author":"Reyes","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.jpsychires.2021.11.025_bib81","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s12640-013-9393-4","article-title":"Altered cytokine and BDNF levels in autism spectrum disorder","volume":"24","author":"Ricci","year":"2013","journal-title":"Neurotox. Res."},{"issue":"S1","key":"10.1016\/j.jpsychires.2021.11.025_bib82","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1037\/tra0000725","article-title":"Coronavirus: a trigger for OCD and illness anxiety disorder?","volume":"12","author":"Rivera","year":"2020","journal-title":"Psychol. Trauma"},{"issue":"13","key":"10.1016\/j.jpsychires.2021.11.025_bib83","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s40265-020-01367-z","article-title":"Pharmaco-immunomodulatory therapy in COVID-19","volume":"80","author":"Rizk","year":"2020","journal-title":"Drugs"},{"issue":"478","key":"10.1016\/j.jpsychires.2021.11.025_bib84","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau5266","article-title":"Modulation of the sigma-1 receptor-IRE1 pathway is beneficial in preclinical models of inflammation and sepsis","volume":"11","author":"Rosen","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.jpsychires.2021.11.025_bib85","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/mp.2008.94","article-title":"The epidemiology of obsessive-compulsive disorder in the national comorbidity survey replication","volume":"15","author":"Ruscio","year":"2010","journal-title":"Mol. Psychiatr."},{"issue":"10223","key":"10.1016\/j.jpsychires.2021.11.025_bib86","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jpsychires.2021.11.025_bib87","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/jcp.30047","article-title":"Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls","volume":"236","author":"Sadeghi","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.jpsychires.2021.11.025_bib88","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/1744666X.2018.1468251","article-title":"Tocilizumab for the treatment of giant cell arteritis","volume":"14","author":"Schirmer","year":"2018","journal-title":"Expet Rev. Clin. Immunol."},{"issue":"9","key":"10.1016\/j.jpsychires.2021.11.025_bib89","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1080\/21645515.2017.1316909","article-title":"Tocilizumab (Actemra)","volume":"13","author":"Sheppard","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"issue":"3","key":"10.1016\/j.jpsychires.2021.11.025_bib90","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13473","article-title":"Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19","volume":"229","author":"Steardo","year":"2020","journal-title":"Acta Physiol."},{"issue":"2","key":"10.1016\/j.jpsychires.2021.11.025_bib91","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1176\/ajp.155.2.264","article-title":"Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases","volume":"155","author":"Swedo","year":"1998","journal-title":"Am. J. Psychiatr."},{"issue":"5","key":"10.1016\/j.jpsychires.2021.11.025_bib92","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S2215-0366(21)00084-5","article-title":"6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records","volume":"8","author":"Taquet","year":"2021","journal-title":"Lancet Psychiatry"},{"issue":"Pt B","key":"10.1016\/j.jpsychires.2021.11.025_bib93","doi-asserted-by":"crossref","first-page":"106275","DOI":"10.1016\/j.yebeh.2019.04.028","article-title":"Inflammation and reactive oxygen species in status epilepticus: biomarkers and implications for therapy","volume":"101","author":"Terrone","year":"2019","journal-title":"Epilepsy Behav."},{"issue":"8","key":"10.1016\/j.jpsychires.2021.11.025_bib94","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s10067-014-2609-z","article-title":"Responsiveness of the EuroQol EQ-5D and hospital anxiety and depression scale (HADS) in rheumatoid arthritis patients receiving tocilizumab","volume":"33","author":"Traki","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jpsychires.2021.11.025_bib95","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbi.2020.04.027","article-title":"Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms","volume":"87","author":"Troyer","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"10","key":"10.1016\/j.jpsychires.2021.11.025_bib96","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S2215-0366(20)30287-X","article-title":"Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study","volume":"7","author":"Varatharaj","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"10234","key":"10.1016\/j.jpsychires.2021.11.025_bib97","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jpsychires.2021.11.025_bib98","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.clinph.2021.03.001","article-title":"Intracortical GABAergic dysfunction in patients with fatigue and dysexecutive syndrome after COVID-19","volume":"132","author":"Versace","year":"2021","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jpsychires.2021.11.025_bib99","article-title":"Long-term respiratory and neurological sequelae of COVID-19","volume":"26","author":"Wang","year":"2020","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.jpsychires.2021.11.025_bib100","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.neuroscience.2013.08.025","article-title":"Brain IL-6 and autism","volume":"252","author":"Wei","year":"2013","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.jpsychires.2021.11.025_bib101","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/glia.23634","article-title":"Microglia responses to interleukin-6 and type I interferons in neuroinflammatory disease","volume":"67","author":"West","year":"2019","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.jpsychires.2021.11.025_bib102","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa205","article-title":"Frequent neurocognitive deficits after recovery from mild COVID-19","volume":"2","author":"Woo","year":"2020","journal-title":"Brain Commun."},{"issue":"1","key":"10.1016\/j.jpsychires.2021.11.025_bib103","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cmi.2020.09.023","article-title":"Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study","volume":"27","author":"Xiong","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"issue":"6","key":"10.1016\/j.jpsychires.2021.11.025_bib104","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41593-021-00837-1","article-title":"Rescue of maternal immune activation-induced behavioral abnormalities in adult mouse offspring by pathogen-activated maternal Treg cells","volume":"24","author":"Xu","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.jpsychires.2021.11.025_bib105","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the \u2018Cytokine Storm\u2019 in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J. Infect."},{"issue":"8","key":"10.1016\/j.jpsychires.2021.11.025_bib106","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00415-020-09929-7","article-title":"Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms","volume":"267","author":"Zhou","year":"2020","journal-title":"J. Neurol."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395621006749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395621006749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:31:30Z","timestamp":1758367890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395621006749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":104,"alternative-id":["S0022395621006749"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2021.11.025","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulating neuroinflammation in COVID-19 patients with obsessive-compulsive disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2021.11.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}